Contineum Therapeutics (CTNM) Institutional Ownership $4.36 -0.16 (-3.54%) As of 10:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)Number ofInstitutional Buyers(last 12 months)34TotalInstitutional Inflows(last 12 months)$130.04MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$12.10M Get CTNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CTNM Institutional Buying and Selling by Quarter Contineum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Squarepoint Ops LLC217,239$3.18M0.0%-37.9%0.843% 2/17/2025Stempoint Capital LP265,833$3.89M1.0%N/A1.031% 2/17/2025Red Tree Management LLC638,158$9.35M6.2%N/A2.475% 2/17/2025Polar Capital Holdings Plc43,604$639K0.0%-79.9%0.169% 2/17/2025Nuveen Asset Management LLC13,307$195K0.0%N/A0.052% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,860$86K0.0%+90.4%0.023% 2/17/2025Janus Henderson Group PLC68,320$1.00M0.0%N/A0.265% 2/17/2025Deutsche Bank AG16,079$236K0.0%N/A0.062% 2/17/2025Bank of America Corp DE9,132$134K0.0%+63.4%0.035% 2/14/2025Schonfeld Strategic Advisors LLC125,995$1.85M0.0%N/A0.489% Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025Northern Trust Corp89,262$1.31M0.0%+42.3%0.346% 2/14/2025MetLife Investment Management LLC7,029$103K0.0%N/A0.027% 2/14/2025Altium Capital Management LLC334,000$4.89M1.4%-9.5%1.296% 2/13/2025Marshall Wace LLP10,836$159K0.0%N/A0.042% 2/13/2025Strategies Wealth Advisors LLC25,000$366K0.0%N/A0.097% 2/13/2025Barclays PLC16,286$239K0.0%+96.0%0.063% 2/13/2025Legal & General Group Plc3,631$53K0.0%+74.0%0.014% 2/13/2025ADAR1 Capital Management LLC82,234$1.21M0.2%+817.1%0.319% 2/13/2025Wells Fargo & Company MN10,755$158K0.0%+419.3%0.042% 2/12/2025Geode Capital Management LLC188,408$2.76M0.0%+46.4%0.731% 2/12/2025Franklin Resources Inc.1,445,565$21.18M0.0%-0.1%5.607% 2/12/2025Norges Bank169,729$2.49M0.0%N/A0.658% 2/12/2025JPMorgan Chase & Co.28,426$416K0.0%+1,040.7%0.110% 2/12/2025WINTON GROUP Ltd39,738$582K0.0%+256.8%0.154% 2/11/2025Corebridge Financial Inc.5,215$76K0.0%+73.1%0.020% 2/6/2025Charles Schwab Investment Management Inc.55,330$811K0.0%+27.8%0.215% 2/4/2025Bank of New York Mellon Corp18,738$275K0.0%+32.3%0.073% 1/30/2025 Rhumbline Advisers8,233$121K0.0%+36.3%0.032% 11/27/2024Franklin Resources Inc.1,447,550$27.71M0.0%+130.9%5.615% 11/19/2024Barclays PLC8,308$158K0.0%+248.6%0.032% 11/16/2024Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500% 11/15/2024Barclays PLC8,308$158K0.0%+248.6%0.032% 11/15/2024State Street Corp113,566$2.17M0.0%+23.7%0.442% 11/14/2024Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687% 11/13/2024BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026% 11/13/2024FMR LLC696,927$13.34M0.0%+115.4%2.710% 11/12/2024Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168% 8/16/2024Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091% 8/16/2024Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259% 8/14/2024Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583% Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment…8/14/2024Sandia Investment Management LP5,000$88K0.1%N/A0.019% 8/9/2024Johnson & Johnson1,979,173$34.85M8.7%N/A7.694% 8/8/2024Versant Venture Management LLC918,163$16.17M20.9%N/A3.569% 8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026% 7/26/2024Bank of New York Mellon Corp20,232$356K0.0%N/A0.079% (Data available from 1/1/2016 forward) CTNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTNM shares? During the previous two years, 37 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), Perceptive Advisors LLC ($27.59M), Franklin Resources Inc. ($21.18M), Versant Venture Management LLC ($16.17M), FMR LLC ($13.34M), and Red Tree Management LLC ($9.35M).Learn more on CTNM's institutional investors. Which institutional investors have been buying Contineum Therapeutics stock? Of the 34 institutional investors that purchased Contineum Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Versant Venture Management LLC ($918.16K), Franklin Resources Inc. ($820.54K), Red Tree Management LLC ($638.16K), FMR LLC ($373.33K), and Stempoint Capital LP ($265.83K). How much institutional buying is happening at Contineum Therapeutics? Institutional investors have bought a total of 7,546,245 shares in the last 24 months. This purchase volume represents approximately $130.04M in transactions. Which Contineum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Contineum Therapeutics stock in the last 24 months: Suvretta Capital Management LLC ($333.33K), Polar Capital Holdings Plc ($173.00K), Squarepoint Ops LLC ($132.76K), Altium Capital Management LLC ($35.13K), Geode Capital Management LLC ($27.75K), Charles Schwab Investment Management Inc. ($8.48K), and Franklin Resources Inc. ($1.99K). How much institutional selling is happening at Contineum Therapeutics? Institutional investors have sold a total of 712,425 shares in the last 24 months. This volume of shares sold represents approximately $12.10M in transactions. Related Companies PGEN Institutional Ownership MNMD Institutional Ownership STOK Institutional Ownership UPB Institutional Ownership PRTC Institutional Ownership SANA Institutional Ownership RVNC Institutional Ownership ABVX Institutional Ownership ZVRA Institutional Ownership HCWB Institutional Ownership This page (NASDAQ:CTNM) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTNM Stock Free CTNM Stock Alerts